Ceapro Inc.
CRPOF · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 9.12 | -0.81 | 29.98 | -1.66 |
| FCF Yield | -0.51% | -0.32% | 0.00% | -0.08% |
| EV / EBITDA | -405.15 | -341.84 | -1,411.05 | -1,711.04 |
| Quality | ||||
| ROIC | -6.72% | -7.49% | -3.65% | -3.52% |
| Gross Margin | 38.26% | 5.93% | 41.24% | 57.27% |
| Cash Conversion Ratio | 1.71 | 0.75 | -0.19 | 0.95 |
| Growth | ||||
| Revenue 3-Year CAGR | -21.84% | -17.56% | -11.56% | -6.42% |
| Free Cash Flow Growth | -71.57% | -4,235.41% | 104.84% | -0.18% |
| Safety | ||||
| Net Debt / EBITDA | 1.34 | 3.14 | 10.13 | 9.87 |
| Interest Coverage | -83.23 | -91.73 | -48.36 | -46.80 |
| Efficiency | ||||
| Inventory Turnover | 0.36 | 0.29 | 0.29 | 0.16 |
| Cash Conversion Cycle | 245.27 | 250.82 | 277.81 | 611.05 |